Jeffrey Chodakewitz, EVP GMDA, CMO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 46,733 shares at $161.00 ($7.5M) on 2017-07-19, disclosed to the SEC on 2017-07-21.
Open-market sale of $7.5M VRTX by EVP GMDA, CMO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $161.00 | 39,833 | $6.4M | 85.3% |
| 2 | $158.08 | 700 | $111K | 1.5% |
| 3 | $158.92 | 1,000 | $159K | 2.1% |
| 4 | $159.85 | 400 | $64K | 0.9% |
| 5 | $161.38 | 3,464 | $559K | 7.4% |
| 6 | $162.04 | 1,336 |
| $216K |
| 2.9% |
| Total | $160.96 avg | 46,733 | $7.5M | 100% |
| Filing → |
| VRTX | SELL | 2018-02-05 | $782K | — | Filing → |
| VRTX | SELL | 2018-01-17 | $351K | — | Filing → |
| VRTX | SELL | 2018-01-03 | $756K | — | Filing → |